Business & Economy · 49 views
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
AI Summary
The FDA rejected ivonescimab, a first‑of‑its‑kind lung‑cancer drug invented in China. The treatment had become a symbol of China’s growing prominence in drug development. The decision marks a setback for the medicine that had been touted as a milestone for Chinese pharmaceutical innovation.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- I inherited $1.4 million from my father. Am I wrong to ask my husband of 25 years for a postnuptial agreement?Continue reading
- Megaspeed Says Alice Huang Left Company in August 2025Continue reading
- ‘It leaves me with a sour taste’: My elderly mother gave our cousin $800 for a car repair. Should I be worried?Continue reading
- Treasury Secretary Scott Bessent says if Nvidia was a bank, ‘a lot of the executives would be removed’ — while Huang reportedly eyes returnContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow